Literature DB >> 9347841

Mammographic density in women on postmenopausal hormone replacement therapy.

W Leung1, F Goldberg, B Zee, E Sterns.   

Abstract

BACKGROUND: Studies have suggested that mammographic density and pattern are affected by hormone replacement therapy (HRT) and may influence breast diagnosis. Because 40% of breast cancers diagnosed at our center are mammographically detected while still clinically occult, mammographic sensitivity is crucial. For this reason we studied the effect of HRT on mammographic density.
METHODS: During a period of 18 months we studied consecutive women older than 54 years attending for breast screening. We recorded HRT use and dosing regimes. A breast density score (BDS) was developed and applied to all mammograms.
RESULTS: Mammograms of 148 HRT users were compared with those of 158 nonusers. HRT users had a significantly higher mean density score (4.7 versus 3.4; p < 0.001). Only 11% of non-HRT users had high scores compared with 37% among HRT users (p < 0.001). The significant difference remained when women were stratified by age. Duration of HRT (longer or shorter than 5 years) did not affect density scores.
CONCLUSIONS: HRT is associated with a significant increase in breast density. In turn, density and mammographic sensitivity are related. The possibility that increased breast density will hamper mammographic diagnosis of clinically occult cancers is worrisome.

Entities:  

Mesh:

Year:  1997        PMID: 9347841     DOI: 10.1016/s0039-6060(97)90072-6

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  7 in total

1.  Mammography in New Hampshire: characteristics of the women and the exams they receive.

Authors:  P A Carney; M E Goodrich; D M O'Mahony; A N Tosteson; M S Eliassen; S P Poplack; S Birnbaum; B G Harwood; K A Burgess; B T Berube; W S Wells; J P Ball; M M Stevens
Journal:  J Community Health       Date:  2000-06

2.  Discovery of breast cancers within 1 year of a normal screening mammogram: how are they found?

Authors:  Patricia A Carney; Elizabeth Steiner; Martha E Goodrich; Allen J Dietrich; Claudia J Kasales; Julia E Weiss; Todd MacKenzie
Journal:  Ann Fam Med       Date:  2006 Nov-Dec       Impact factor: 5.166

Review 3.  Postmenopausal hormone replacement therapy: effects on normal mammary gland in humans and in a mouse postmenopausal model.

Authors:  Sandra Z Haslam; Janet R Osuch; A M Raafat; L J Hofseth
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

4.  Mammographic density in postmenopausal women treated with tibolone, estriol or conventional hormone replacement therapy.

Authors:  I Valdivia; D Ortega
Journal:  Clin Drug Investig       Date:  2000       Impact factor: 2.859

5.  Endometriosis and mammographic density measurements in the Nurses' Health Study II.

Authors:  Leslie V Farland; Rulla M Tamimi; A Heather Eliassen; Donna Spiegelman; Kimberly A Bertrand; Stacey A Missmer
Journal:  Cancer Causes Control       Date:  2016-08-22       Impact factor: 2.506

6.  Long-term excess risk of breast cancer after a single breast density measurement.

Authors:  Matejka Rebolj; Oleg Blyuss; Kee Seng Chia; Stephen W Duffy
Journal:  Eur J Cancer       Date:  2019-06-21       Impact factor: 9.162

7.  Red-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165].

Authors:  Charlotte Atkinson; Ruth M L Warren; Evis Sala; Mitch Dowsett; Alison M Dunning; Catherine S Healey; Shirley Runswick; Nicholas E Day; Sheila A Bingham
Journal:  Breast Cancer Res       Date:  2004-02-24       Impact factor: 6.466

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.